SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-024723
Filing Date
2022-11-14
Accepted
2022-11-14 08:15:33
Documents
13
Period of Report
2022-11-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20221114.htm   iXBRL 8-K 62158
2 EX-99.1 crnx-ex99_1.htm EX-99.1 208157
  Complete submission text file 0000950170-22-024723.txt   399294

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT crnx-20221114_pre.xml EX-101.PRE 9842
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT crnx-20221114_lab.xml EX-101.LAB 13350
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT crnx-20221114.xsd EX-101.SCH 2472
7 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20221114_htm.xml XML 4726
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 221380520
SIC: 2834 Pharmaceutical Preparations